Kirkland & Ellis LLP

06/15/2026 | Press release | Distributed by Public on 06/15/2026 11:47

Kirkland Advises Abry Partners on Close of $780 Million Oversubscribed Continuation Vehicle for Centauri Health Solutions

Kirkland & Ellis advised private equity firm Abry Partners on the closing of a $780 million continuation vehicle to extend its active partnership with Centauri Health Solutions, a market-leading healthcare technology company that delivers data-driven solutions to U.S. health plans. Funds managed by Neuberger Private Markets and Apollo's Sponsor and Secondary Solutions business served as co-lead investors in the transaction, which provided existing limited partners with optional liquidity and raised additional committed capital to support Centauri's continued growth and execution of its value creation strategy. Centauri provides mission-critical technology, data intelligence and member engagement solutions to U.S. health plans, helping payers maximize revenue accuracy, quality performance and member outcomes.

Read Abry's announcement

The Kirkland team included investment funds lawyers Mark Boyagi, Semhar Woldai, Ethan Green, David Sherman, James Rouchard, Ashley Lee, Sy Yaw and Ria Sen; corporate lawyers Dave Gusella, Marion Racine, Dan Vaczy, Dylan Rogalin, Katie Heffernan, Tamie Daniels and Michael McShane; tax lawyers Brandon Short, Vin Thorn and Daniel Henry; executive compensation lawyers Matt Wood, Matt Mutino and Rebecca Arnall; investment funds regulatory lawyers Nabil Sabki, Jina Yun and Paige Tapp; investment funds ERISA lawyers Sabrina Glaser and Ted Brown; antitrust & competition lawyer Max Melion; and transactional liability lawyer Hayley Hollender.

Kirkland & Ellis LLP published this content on June 15, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 15, 2026 at 17:47 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]